Keywords: novartis, open, new, faciltiy, china, million, investment

Novartis to open new R&D faciltiy in China, with $100 million investment

Article | 13 November 2006

Print This

Swiss pharmaceutical major Novartis has announced plans to create a new strategic biomedical R&D center in Shanghai, China. An ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in